Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Ketosis

• Effect of Nutritional Ketosis on Alcohol Metabolism
• SGLT2 Inhibitors, Ketogenesis, and Ketoacidosis
• 0.9% Saline Versus Balanced Solutions in Severe Diabetic Ketoacidosis
• Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosis
• Low-CArbohydrate Diet and SGLT2-INhibitOr to Achieve Moderate Ketosis in Healthy Volunteers
• Comparison of a Low Dose to a Standard Dose of Insulin in Adult DKA in ICU to Reduce Metabolic Complications
• Outcome of Glargine Insulin in Renal Impairment Patients With Diabetic Ketoacidosis
• Concurrent Subcutaneous Basal Insulin and Intravenous Insulin Pump in Hyperglycemic Crisis Patients Under Critical Care
• Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management
• Nutritional Ketosis in Heart Failure
• Comparison of the Short-Term Effect of Dietary Carbohydrate Restriction Versus Exogenous Ketone Supplementation on Myocardial Glucose Suppression and Timing to Achieve a State of Ketosis Using FDG PET/CT Serial Imaging
• Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D)
• Metabolic Responses of Dapagliflozin vs Sitagliptin in T2DM Patients Inadequately Controlled With Insulin Therapy
• Thiamine as Adjunctive Therapy for Diabetic Ketoacidosis
• Effects of Ketone Bodies on Cognition in Type 2 Diabetes
• Early Glargine (Lantus) in DKA Management in Children With Type 1 Diabetes
• Double Blinded Randomized Control Trial of Types of IVF in Children With DKA
• Insulin Degludec for the Management of Patient With Recurrent Diabetic Ketoacidosis
• Early Subcutaneous Insulin Glargine Plus Standard of Care for Treatment of Diabetic Ketoacidosis
• Oral Glucose Intervention for Children With Gastroenteritis and Ketosis
• Study on Incidence of Diabetic Ketoacidosis Among Participants With Type 2 Diabetes Mellitus Treated With Sodium-glucose Co-transporter 2 (SGLT2) Inhibitors or Other Antihyperglycemic Agents
• Early Administration of Long-acting Insulin Treatment of Diabetic Ketoacidosis in Pediatric Type 1 Diabetes
• Fluid Kinetics in Patients With Diabetic Ketoacidosis
• Metabolic Signalling in Muscle- and Adipose-tissue Following Insulin Withdrawal and Growth Hormone Injection.
• Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosis
• Anti-IL-1 Treatment in Children Diabetic Keto-Acidosis (DKA) at Diagnosis of Type 1 Diabetes
• Randomized Control Trial of Fluid Therapy for Pediatric Diabetic Ketoacidosis
• Ketosis-Prone Diabetes Mellitus (KPDM): Metformin Versus Sitagliptin Treatment
• Subcutaneous Aspart Insulin to Treat Diabetic Ketoacidosis (DKA) and Beta-Hydroxybutyrate Testing in DKA
• Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA)
• Ketosis Prone Diabetes in African-Americans
• Use of Insulin Glargine to Treat Diabetic Ketoacidosis